Snowy Owl
Retired in 2010, In Memoriam
???...British Medical Journal, Helping doctors make better decisions...???
BMJ 2007;334 (30 June), doi:10.1136/bmj.39259.443646.47
Editor's Choice ???FAFfing about
Tony Delamothe, deputy editor</STRONG>
tdelamothe@bmj.com<SCRIPT type=text/javascript><!-- var u = "tdelamothe", d = "bmj.com"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></SCRIPT>
Somewhere, I imagine, there's a small group of people proud<SUP> </SUP>to be counted among the Friends of Avian Flu, or FAF for short.<SUP> </SUP>
I suspect they have a catchy mission statement, such as "Keeping<SUP> </SUP>the nightmare alive," and lapel badges of vaguely bird-like<SUP> </SUP>shape.<SUP> </SUP>
Their challenge is to keep bird flu forever in the public eye.<SUP> </SUP>This should be getting harder, as influenza H5N1 is proving<SUP> </SUP>particularly resistant to undergoing the killer mutation that<SUP> </SUP>would allow efficient human to human transmission of the virus.<SUP> </SUP>
Ten years after the strain first appeared in humans, it has<SUP> </SUP>killed just 191 people.
This is despite the most propitious<SUP> </SUP>of circumstances: millions of people and poultry living in very<SUP> </SUP>close proximity in South East Asia. Although these deaths are<SUP> </SUP>a tragedy for the victims and their families, it's as well to<SUP> </SUP>remember that a similar number of people die on the roads world<SUP> </SUP>wide every 84 minutes.<SUP> </SUP>
<SUP></SUP>
Traditionally, we've blamed the drug companies for talking up<SUP> </SUP>the risks of diseases, or even inventing diseases, but this<SUP> </SUP>is not the case with bird flu.
The track record of oseltamivir<SUP> </SUP>(Tamiflu) as a treatment for H5N1 is decidedly mixed, and its<SUP> </SUP>use in seasonal flu has been linked to suicides and neuropsychiatric<SUP> </SUP>symptoms in Japanese teenagers.
FAF has incorporated this pharmaceutical<SUP> </SUP>failure into its story for bird flu: The Drugs Don't Work. Be<SUP> </SUP>afraid. Be very afraid.<SUP> </SUP>
<SUP></SUP>
FAF knows that the best way to generate column inches is high<SUP> </SUP>profile scientific conferences with well oiled media machines,<SUP> </SUP>and in this week's BMJ Richard Smith, our previous editor, reports<SUP> </SUP>on a session he chaired at a conference of Health Technology<SUP> </SUP>Assessment International (doi: 10.1136/bmj.39255.606713.DB).<SUP> </SUP>
Some of the observations were familiar: the inevitability of<SUP> </SUP>the pandemic and the possibility of drug resistance.
But others<SUP> </SUP>were relatively new: the terminological mutation from "avian<SUP> </SUP>flu" to "pandemic flu," in recognition of H5N1's failure to<SUP> </SUP>mutate genetically.<SUP> </SUP>
<SUP></SUP>
H5N1 had been groomed for stardom, but now it can be any influenza<SUP> </SUP>strain that becomes pandemic, further details unknown.
As influenza<SUP> </SUP>pandemics occurred in 1918, 1957, and 1968, another one is likely.<SUP> </SUP>But why should we be any more worried in 2007 than in 1997 or<SUP> </SUP>2017?
Couldn't those responsible for planning for the next pandemic<SUP> </SUP>do their planning less publicly and put the frighteners on the<SUP> </SUP>rest of us at the appropriate time?<SUP> </SUP>
For AIDS, however, it really is apocalypse now. Sceptics used<SUP> </SUP>to point out that there were more papers on AIDS than people<SUP> </SUP>with the condition, but that was a very long time ago.
Sixty<SUP> </SUP>million people have now been infected with HIV and another 14<SUP> </SUP>000 are acquiring the infection every day.
A vaccine against<SUP> </SUP>HIV would seem the best way to halt the AIDS epidemic, but as<SUP> </SUP>Alison Tonks points out in her review, an effective vaccine<SUP> </SUP>is as far away as ever (doi: 10.1136/bmj.39240.416968.AD).
The<SUP> </SUP>AIDS Vaccine Advocacy Coalition regards it as more challenging<SUP> </SUP>than landing a man on the moon. "When it came down to the space<SUP> </SUP>race, we knew where we were; we knew where the moon was; and<SUP> </SUP>we knew, roughly, how to get there. It was, essentially, an<SUP> </SUP>engineering problem. When it comes to an AIDS vaccine, we don't<SUP> </SUP>know where the moon is?yet."<SUP> </SUP>
<SUP></SUP>
<!-- null -->Related Articles
<DL><DT>Social measures may control pandemic flu better than drugs and vaccines <DD>Richard Smith
BMJ 2007 334: 1341. <NOBR>[Extract] [Full Text] </NOBR>
</DD></DL><DL><DT>Quest for the AIDS vaccine <DD>Alison Tonks
BMJ 2007 334: 1346-1348. <NOBR>[Extract] [Full Text] </NOBR>
</DD></DL><!-- eletters -->